Wednesday, March 29, 2023
wellness India Expo
Home Tags DBT

Tag: DBT

“Innovations played a major role in India’s pandemic response”

Dr Taslimarif Saiyed, CEO and Director, Centre for Cellular and Molecular Platforms (C-CAMP), shares his thoughts on the India’s biotech R&D

Govt launches VAIBHAV fellowships for Indian diaspora abroad

Vaibhav Fellowship aims at collaboration between best of Diaspora Minds with Domestic Minds to deliver world class projects and products

Bugworks Research welcomes Dr Renu Swarup to its Global Advisory Board

Former secretary of the Department of Biotechnology, Government of India and reputed Biotechnologist joins the Advisory Board to provide strategic guidance to the project portfolio of Bugworks Research

India developed four indigenous vaccines in just two years: Dr Jitendra...

DBT through “Mission COVID Suraksha”, delivered four vaccines, augmented the manufacturing of Covaxin

Govt’s particular focus on strengthening S&T ecosystems: Agriculture Minister

Narendra Singh Tomar was speaking during the closing ceremony of India International Science Festival (IISF)-2022 on January 24, 2023

IISF 2022: Startup Conclave to focus on Biotech Innovation Ecosystem

The conclave will showcase the outcomes of the largest funding schemes in the biotech sector, namely, the Biotech Ignition Grant (BIG) for entrepreneurs and startups and the BioNEST scheme for bio-incubation centres

Dr Ramesh Venkata Sonti is the new Director of ICGEB

He succeeds Dr Dinakar M. Salunke who was at the helm for over six years

DBT funded 51 Biotech-Kisan hubs connecting Indian farmers with best scientists

The programme has benefitted over four lakhs farmers by increasing their agriculture output and income and created 200 entrepreneurs in rural areas

BioVoice eMagazine December 2022 Issue 3 Volume 3

Click to Read: BioVoice eMagazine December 2022 Issue 3 Volume 3 The Cover Story in the current edition focuses on India's strong biotech R&D segment...

Exclusive: Antibody against multiple emerging SARS-CoV-2 variants

A broadly neutralizing highly potent human monoclonal antibody developed in India against multiple emerging SARS-CoV-2 variants